Home

Research

Read time: 2 min

Congress highlights

New insights from a poster at IHC2021 on how patients respond when switched from one anti-CGRP monoclonal antibody to another

What is the effect of switching to a second anti-CGRP monoclonal antibody when migraine fails to...

Anxiety, Depression

Read time: 2 min

Satellite symposium

Anxious distress and major depressive disorder: Recognition, assessment and treatment

In an industry-sponsored symposium (Servier Laboratories), titled ‘Anxiety symptoms in...

Alzheimer's Disease

Read time: 4 min

Congress highlights

Biofluid-based biomarkers – realizing their potential in Alzheimer’s disease

Henrik Zetterberg, University of Gothenberg, Sweden and University College London, UK, during the...

Read time: 3 min

Congress highlights

Insights into migraine mechanisms: a central brain disorder with peripheral inputs

Speaking at #WCN2021, Professor Todd Schwedt, of the Mayo Clinic, USA summarized that although...

Parkinson's Disease

Read time: 2 min

Congress highlights

How do microglia and astrocytes contribute to neurodegeneration in PD?

Immune responses are involved in the pathophysiology of Parkinson’s disease. Supporting...

Read time: 2 min

Satellite symposium

Anti-CGRP monoclonal antibodies in the real world

When are anti-CGRP monoclonal antibodies used for migraine in the real world, how effective are...

Alzheimer's Disease

Read time: 4 min

Mild cognitive impairment – signs and susceptibility

Understanding the pre-symptomatic changes underlying Alzheimer’s disease and other dementias...

Read time: 3 min

Satellite symposium

The role of brain circuits in mental illness

Traditional psychiatry based on symptoms-based disorder categories is limited by poor understanding...

Read time: 2 min

Congress highlights

Inflammation and glutamate dysregulation: unravelling the aetiology of schizophrenia

Reduced glutamatergic signalling and immune dysregulation are two major aetiological hypotheses in...

Read time: 2 min

Congress highlights

What causes migraine and how can it be prevented?

"Calcitonin gene-related peptide (CGRP) plays a causative role in migraine", said...

Alzheimer's Disease, Parkinson's Disease

Read time: 3 min

Congress highlights

Sex differences in Alzheimer’s and Parkinson’s diseases

"Determining sex differences in disease phenotypes is the gateway to precision medicine...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country